Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IPSC

Century Therapeutics Inc

Apr 17 • 04:00PM ET

2.60

+0.16 6.56 %

Healthcare • Biotechnology • USA • NASD

Peers: CRSP EDIT NTLA BEAM DNLI ARCT SGMO VERV CARR ZNTL

| Held by: VTI VXF AVSC PRFZ DFAS DFMC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.11	Insider Own	36.41%	Shs Outstand	179.72M	Perf Week	15.56%
Market Cap	467.28M	Forward P/E	-	EPS next Y	-0.47	Insider Trans	0.13%	Shs Float	114.29M	Perf Month	13.04%
Enterprise Value	392.93M	PEG	-	EPS next Q	-0.14	Inst Own	38.28%	Short Float	9.00%	Perf Quarter	13.04%
Income	-9.57M	P/S	4.28	EPS this Y	-283.93%	Inst Trans	10.98%	Short Ratio	7.22	Perf Half Y	356.46%
Sales	109.16M	P/B	1.43	EPS next Y	12.09%	ROA	-3.32%	Short Interest	10.29M	Perf YTD	161.36%
Book/sh	1.82	P/C	3.96	EPS next 5Y	-	ROE	-5.98%	52W High	3.04 -14.47%	Perf Year	378.20%
Cash/sh	0.66	P/FCF	-	EPS past 3/5Y	63.45% 35.31%	ROIC	-4.81%	52W Low	0.44 497.70%	Perf 3Y	-17.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	175.88% -	Gross Margin	88.00%	Volatility	7.87% 8.93%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.60	EPS Y/Y TTM	93.57%	Oper. Margin	-13.77%	ATR (14)	0.20	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.97	Sales Y/Y TTM	1556.51%	Profit Margin	-8.77%	RSI (14)	61.56	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	5.97	EPS Q/Q	48.43%	SMA20	14.76%	Beta	1.65	Target Price	4.20
Payout	-	Debt/Eq	0.27	Sales Q/Q	-100.00%	SMA50	16.22%	Rel Volume	1.32	Prev Close	2.44
Employees	78	LT Debt/Eq	0.25	Earnings	Mar 12 BMO	SMA200	126.98%	Avg Volume	1.42M	Price	2.60
IPO	Jun 18, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	13.79% -	Trades		Volume	1,886,849	Change	6.56%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-25-26	Initiated	TD Cowen	Buy
Aug-08-24	Initiated	Rodman & Renshaw	Buy	$6
Aug-28-23	Downgrade	JP Morgan	Overweight → Neutral	$28 → $5
Dec-27-22	Initiated	Chardan Capital Markets	Buy	$19
Oct-31-22	Initiated	Guggenheim	Buy	$15
Oct-10-22	Initiated	Canaccord Genuity	Buy	$28
May-23-22	Initiated	H.C. Wainwright	Buy	$27
May-12-22	Initiated	William Blair	Mkt Perform
Jul-13-21	Initiated	Piper Sandler	Overweight	$38
Jul-13-21	Initiated	JP Morgan	Overweight	$40
Jul-13-21	Initiated	BofA Securities	Buy	$34

Show Previous Ratings

Mar-12-26 08:00AM	Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates (GlobeNewswire) -8.42%
Feb-25-26 08:00AM	Century Therapeutics to Participate in Upcoming Investor Conferences in March (GlobeNewswire)
Jan-30-26 02:58PM	Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission (Insider Monkey) -5.47%
Jan-22-26 12:00PM	Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know (Zacks) +13.24%
Jan-08-26 08:00AM	Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 Diabetes (GlobeNewswire) +36.15%
11:45AM	Loading…
Jan-07-26 11:45AM	FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug (Zacks) +44.44%
08:55AM	Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain (Zacks)
Dec-09-25 08:55AM	Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors (Zacks)
08:00AM	Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors (GlobeNewswire)
Nov-25-25 04:01PM	Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-13-25 07:30AM	Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire) -17.54%
07:00AM	Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes (GlobeNewswire)
Oct-14-25 04:01PM	Century Therapeutics to Present at Chardan's 9th Annual Genetic Medicines Conference (GlobeNewswire)
Aug-22-25 08:00AM	Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference (GlobeNewswire)
Aug-14-25 04:01PM	Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
12:00PM	Loading…
Jul-21-25 12:00PM	All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy (Zacks)
Jul-15-25 08:50AM	Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock (Zacks)
Jun-25-25 08:50AM	Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum (Zacks)
Jun-06-25 08:50AM	Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain (Zacks) +9.47%
May-28-25 04:01PM	Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress (GlobeNewswire)
May-15-25 08:15PM	Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates (Zacks) +5.79% +8.23%
04:01PM	Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-14-25 05:10PM	Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates (Zacks) -7.02%
May-13-25 05:25PM	Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-01-25 10:01AM	Century Therapeutics, Inc. (IPSC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
08:20AM	Madrigal (MDGL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-28-25 04:30PM	Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting (GlobeNewswire)
Apr-15-25 04:01PM	Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025 (GlobeNewswire)
Mar-25-25 12:00PM	Century Therapeutics (IPSC) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-19-25 05:15PM	Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -5.66%
04:01PM	Loading…
04:01PM	Century Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire)
Jan-21-25 07:00AM	Century Therapeutics Announces Investigator-Initiated Phase 1/2 Trial of its iPSC-derived iNK Cell Therapy CNTY-101 in B-cell Mediated Autoimmune Diseases Sponsored by Internationally Renowned Key Opinion Leaders (GlobeNewswire)
Nov-26-24 07:00AM	Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire)
Nov-08-24 12:00PM	What Makes Century Therapeutics (IPSC) a New Buy Stock (Zacks)
Nov-05-24 10:15AM	Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +5.56%
09:05AM	Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
09:00AM	Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Nov-04-24 07:00AM	Century Therapeutics to Present at Guggenheim's Inaugural Healthcare Innovation Conference (GlobeNewswire)
Sep-26-24 07:00AM	Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer (GlobeNewswire)
Aug-08-24 08:50AM	Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Jul-09-24 12:00PM	Century Therapeutics (IPSC) Moves to Buy: Rationale Behind the Upgrade (Zacks)
Jun-03-24 07:00AM	Century Therapeutics Presents Interim Results from Phase 1 ELiPSE-1 Study at ASCO 2024 Annual Meeting (GlobeNewswire)
May-10-24 03:35PM	Century Therapeutics Inc (IPSC) Q1 2024 Earnings: Aligns with EPS Projections Amid Strategic ... (GuruFocus.com)
07:00AM	Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting (GlobeNewswire)
May-09-24 01:54PM	IPSC Stock Earnings: Century Therapeutics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
08:40AM	Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-23-24 07:00AM	Century Therapeutics to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit (GlobeNewswire)
Apr-11-24 08:25AM	Century buys a startup, raises funding in cell therapy expansion (BioPharma Dive) +7.14%
07:00AM	Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics (GlobeNewswire)
Apr-08-24 04:05PM	Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire) +6.08%
Mar-25-24 07:00AM	Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors (GlobeNewswire) -9.48%
Mar-19-24 07:00AM	Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference (GlobeNewswire)
Mar-14-24 01:52PM	IPSC Stock Earnings: Century Therapeutics Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace) -7.20%
07:30AM	Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-08-24 11:55PM	Century Therapeutics Inc (IPSC) COO Adrienne Farid Sells 53,515 Shares (GuruFocus.com)
Mar-07-24 09:55AM	How Much Upside is Left in Century Therapeutics, Inc. (IPSC)? Wall Street Analysts Think 193.4% (Zacks) +6.30%
Mar-05-24 06:03PM	Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting (GlobeNewswire) +17.65%
Feb-01-24 07:00AM	Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference (GlobeNewswire)
Dec-09-23 12:00PM	Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion Edits (GlobeNewswire)
Dec-07-23 11:01AM	Century (IPSC) Up 36% on FDA Nod to Begin Phase I Lupus Study (Zacks) +8.37%
Dec-06-23 07:30AM	Century Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data from Phase 1 ELiPSE-1 trial of CNTY-101 in Relapsed or Refractory B-cell Lymphomas and Planned Phase 1 Study in Systemic Lupus Erythematosus (GlobeNewswire) +36.08%
07:30AM	Century Therapeutics Receives FDA Clearance of IND Application for CNTY-101 in Systemic Lupus Erythematosus (GlobeNewswire)
Dec-05-23 08:55AM	Penny Stock Jackpots: 3 High-Stakes Picks With 10-Bagger Potential (InvestorPlace)
Nov-21-23 07:00AM	Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference (GlobeNewswire)
Nov-14-23 03:58PM	FMR LLC Adjusts Position in Century Therapeutics Inc (GuruFocus.com)
Nov-09-23 08:29AM	Century Therapeutics Inc (IPSC) Reports Q3 2023 Financial Results (GuruFocus.com) -13.13%
07:01AM	Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
07:00AM	Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer (GlobeNewswire)
07:00AM	Century Therapeutics and FUJIFILM Cellular Dynamics Announce Licenses for the Development and Commercialization of iPSC-Derived Cell Therapies in Autoimmune and Inflammatory Diseases (GlobeNewswire)
Nov-02-23 09:00AM	Century Therapeutics to Present Initial Clinical Data Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion Edits at the 65th ASH Annual Meeting and Exposition (GlobeNewswire)
Sep-26-23 07:00AM	Century Therapeutics to Present at the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Aug-09-23 08:50AM	Century Therapeutics, Inc. (IPSC) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-01-23 06:48AM	Century Therapeutics (NASDAQ:IPSC) shareholders have endured a 71% loss from investing in the stock a year ago (Simply Wall St.)
May-12-23 06:11AM	Century Therapeutics First Quarter 2023 Earnings: Revenues Beat Expectations, EPS Lags (Simply Wall St.)
May-11-23 08:55AM	Century Therapeutics, Inc. (IPSC) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-17-23 07:00AM	Century Therapeutics to Present at Chardans 7th Annual Genetic Medicines & Cell Therapy Manufacturing Virtual Summit (GlobeNewswire)
Apr-12-23 08:30AM	Century Therapeutics Announces Leadership Changes (GlobeNewswire) -7.91%
Mar-16-23 08:55AM	Century Therapeutics, Inc. (IPSC) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:30AM	Century Therapeutics Reports Full Year 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Mar-15-23 04:01PM	Century Therapeutics to Present at the AACR Annual Meeting 2023 (GlobeNewswire)
Feb-21-23 07:00AM	Century Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Feb-08-23 07:30AM	Century Therapeutics Announces First Patient Dosed in First-In-Human Phase 1 ELiPSE-1 Trial Evaluating CNTY-101 in Relapsed or Refractory CD19 Positive B-cell Lymphomas (GlobeNewswire)
Feb-01-23 07:00AM	Century Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire)
Jan-17-23 09:35AM	After Plunging -29.84% in 4 Weeks, Here's Why the Trend Might Reverse for Century Therapeutics, Inc. (IPSC) (Zacks) -7.36%
Jan-09-23 10:46AM	Century Therapeutics becomes latest life sciences company to enact layoffs, narrow focus (American City Business Journals)
Jan-06-23 08:23AM	Century Therapeutics Announces Internal Portfolio Prioritization, Analyst Views It As Incrementally Positive (Benzinga)
Jan-05-23 04:01PM	Century Therapeutics Announces Internal Portfolio Prioritization to Extend Cash Runway Into 2026 (GlobeNewswire)
Jan-04-23 07:00AM	Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-08-22 10:02AM	Further weakness as Century Therapeutics (NASDAQ:IPSC) drops 12% this week, taking one-year losses to 39% (Simply Wall St.)
Nov-22-22 07:00AM	Century Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire) +5.24%
Nov-11-22 07:00AM	Century Therapeutics Announces Presentation of Preclinical Data at the SITC 37th Annual Meeting and Provides Pipeline Updates (GlobeNewswire) -5.01%
Nov-10-22 08:45AM	Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +15.11%
07:30AM	Century Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-02-22 07:05AM	Century Therapeutics to Host Virtual Research and Development Day on November 11, 2022 (GlobeNewswire)
Oct-05-22 04:05PM	Century Therapeutics to Present at the SITC 37th Annual Meeting (GlobeNewswire)
Oct-03-22 07:00AM	Century Therapeutics Announces Appointment of Daphne Quimi and Timothy Walbert to its Board of Directors (GlobeNewswire)

Century Therapeutics, Inc. engages in the development of off-the-shelf cell therapies to advance the course of cancer care. It focuses on harnessing the power of adult stem cells to develop curative allogeneic cell therapies for cancer. The company was founded by Marcela Maus and Hiromitsu Nakauchi in 2018 and is headquartered in Philadelphia, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Carr Douglas	SVP Finance & Operations	Mar 12 '26	Sale	2.55	7,043	17,953	507,261	Mar 16 04:04 PM
Russotti Gregory	See Remarks	Mar 12 '26	Sale	2.55	10,076	25,684	515,427	Mar 16 04:03 PM
Russotti Gregory	Officer	Mar 12 '26	Proposed Sale	2.55	10,076	25,686		Mar 12 04:23 PM
Russotti Gregory	See Remarks	Mar 09 '26	Sale	2.54	479	1,215	525,503	Mar 11 04:11 PM
Russotti Gregory	Officer	Mar 09 '26	Proposed Sale	2.54	479	1,215		Mar 09 03:15 PM
Carr Douglas	SVP Finance & Operations	Feb 03 '26	Sale	1.82	323	589	514,551	Feb 05 04:14 PM
Cowan Chad	Chief Scientific Officer	Dec 22 '25	Buy	0.85	58,060	49,252	1,045,087	Dec 29 04:52 PM
Pfeiffenberger Brent	President and CEO	Dec 12 '25	Buy	0.58	52,000	30,352	3,322,990	Dec 16 06:38 PM
Carr Douglas	SVP Finance & Operations	Dec 08 '25	Sale	0.53	257	137	404,874	Dec 10 04:34 PM
Russotti Gregory	See Remarks	Dec 08 '25	Sale	0.53	526	280	390,982	Dec 10 04:34 PM
Pfeiffenberger Brent	Officer	Dec 08 '25	Proposed Sale	0.53	476	253		Dec 08 03:29 PM
Russotti Gregory	Officer	Dec 08 '25	Proposed Sale	0.53	526	280		Dec 08 03:17 PM
Cowan Chad	Chief Scientific Officer	Nov 20 '25	Sale	0.50	5,462	2,736	987,027	Nov 24 04:05 PM
Pfeiffenberger Brent	President and CEO	Nov 19 '25	Buy	0.50	35,000	17,328	3,271,453	Nov 20 06:02 PM
Cowan Chad	Officer	Nov 20 '25	Proposed Sale	0.50	5,462	2,739		Nov 20 03:15 PM
Pfeiffenberger Brent	President and CEO	Nov 17 '25	Sale	0.45	32,456	14,735	3,236,453	Nov 19 04:19 PM
Pfeiffenberger Brent	Officer	Nov 17 '25	Proposed Sale	0.45	32,456	14,732		Nov 17 04:16 PM
Carr Douglas	SVP Finance & Operations	Nov 03 '25	Sale	0.59	292	171	405,131	Nov 05 04:01 PM
Carr Douglas	SVP Finance & Operations	Sep 08 '25	Sale	0.50	263	132	405,423	Sep 10 05:34 PM
Pfeiffenberger Brent	President and CEO	Sep 08 '25	Sale	0.50	488	244	3,268,909	Sep 10 05:29 PM
Russotti Gregory	See Remarks	Sep 08 '25	Sale	0.50	539	270	391,508	Sep 10 05:28 PM
Pfeiffenberger Brent	Officer	Sep 08 '25	Proposed Sale	0.50	488	244		Sep 08 03:28 PM
Russotti Gregory	Officer	Sep 08 '25	Proposed Sale	0.50	539	269		Sep 08 03:11 PM
Pfeiffenberger Brent	Officer	Aug 18 '25	Proposed Sale	0.57	30,745	17,522		Aug 18 04:24 PM
Carr Douglas	SVP Finance & Operations	Aug 04 '25	Sale	0.53	296	158	405,686	Aug 06 04:13 PM
Carr Douglas	SVP Finance & Operations	Jun 09 '25	Sale	0.62	4,904	3,050	405,982	Jun 11 05:05 PM
Farid Adrienne	Chief Operations Officer	Jun 09 '25	Sale	0.62	552	343	250,141	Jun 11 05:05 PM
Pfeiffenberger Brent	President and CEO	Jun 09 '25	Sale	0.62	475	295	1,681,783	Jun 11 05:05 PM
Russotti Gregory	See Remarks	Jun 09 '25	Sale	0.62	526	327	392,047	Jun 11 05:04 PM
Pfeiffenberger Brent	Officer	Jun 09 '25	Proposed Sale	0.62	475	296		Jun 09 03:15 PM
Farid Adrienne	Officer	Jun 09 '25	Proposed Sale	0.62	552	343		Jun 09 03:13 PM
Russotti Gregory	Officer	Jun 09 '25	Proposed Sale	0.62	526	327		Jun 09 03:09 PM
Pfeiffenberger Brent	President and CEO	May 16 '25	Sale	0.55	29,552	16,135	1,682,258	May 20 04:19 PM
Pfeiffenberger Brent	Officer	May 16 '25	Proposed Sale	0.55	29,552	16,138		May 16 03:47 PM
Farid Adrienne	Chief Operations Officer	May 05 '25	Sale	0.55	1,024	563	250,693	May 07 04:38 PM
Carr Douglas	SVP Finance & Operations	May 05 '25	Sale	0.55	295	162	410,886	May 07 04:38 PM
Farid Adrienne	Officer	May 05 '25	Proposed Sale	0.55	1,024	563		May 05 03:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IPSC

Century Therapeutics Inc

Upgrade your Finviz experience